User profiles for Francesco La Torre

Francesco La Torre

MD, Reumatologia Pediatrica, Ospedale Pediatrico Giovanni XXIII, Bari
Verified email at virgilio.it
Cited by 1846

Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry

…, S Viola, R De Marco, L Breda, F La Torre… - The Journal of …, 2013 - jrheum.org
Objective. To evaluate safety and efficacy of adalimumab (ADA) and infliximab (IFX) for the
treatment of juvenile idiopathic arthritis-related anterior uveitis (JIA-AU). Methods. Starting …

[HTML][HTML] Environmental contamination by canine geohelminths

…, A Frangipane di Regalbono, A Di Cesare, F La Torre… - Parasites & vectors, 2014 - Springer
Intestinal nematodes affecting dogs, ie roundworms, hookworms and whipworms, have a
relevant health-risk impact for animals and, for most of them, for human beings. Both dogs and …

Methotrexate treatment in juvenile localized scleroderma: a randomized, double‐blind, placebo‐controlled trial

…, F Falcini, A Patrizi, M Alessio, FL Torre… - Arthritis & …, 2011 - Wiley Online Library
Objective Juvenile localized scleroderma is a chronic progressive fibrotic disorder of the
skin that causes permanent disability and aesthetic damage. This study was undertaken to …

[HTML][HTML] Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic …

…, RM Dellepiane, MC Maggio, F La Torre… - Pediatric …, 2021 - Springer
Background There is mounting evidence on the existence of a Pediatric Inflammatory
Multisystem Syndrome-temporally associated to SARS-CoV-2 infection (PIMS-TS), sharing …

Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

…, A Kondi, L Kröger, F La Torre… - The Lancet Child & …, 2019 - thelancet.com
Background To our knowledge, the characteristics and burden of childhood arthritis have
never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study…

Synthesis, Molecular Modeling Studies, and Selective Inhibitory Activity against Monoamine Oxidase of 1-Thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole …

…, S Alcaro, F Ortuso, R Cirilli, F La Torre… - Journal of medicinal …, 2005 - ACS Publications
A novel series of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)-pyrazole derivatives have been
synthesized and investigated for the ability to inhibit selectively the activity of the A and B …

[HTML][HTML] Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting

G Ferrara, G Mastrangelo, P Barone, F La Torre… - Pediatric …, 2018 - Springer
Background Conventional pharmacological therapies for the treatment of juvenile idiopathic
arthritis (JIA) consist of non-biological, disease-modifying antirheumatic drugs, among …

Synthesis and Selective Inhibitory Activity of 1-Acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole Derivatives against Monoamine Oxidase

…, B Mondovì, R Cirilli, F La Torre - Journal of medicinal …, 2004 - ACS Publications
A novel series of 1-acetyl-3-(4-hydroxy- and 2,4-dihydroxyphenyl)-5-phenyl-4,5-dihydro-(1H)-pyrazole
derivatives 1−12 have been synthesized and investigated for the ability to …

[HTML][HTML] Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group …

…, R Cimaz, SD Paolera, G Filocamo, F La Torre… - Italian journal of …, 2021 - Springer
Background Italy was the first Western country to be hit by the SARS-CoV-2 epidemic. There
is now mounting evidence that a minority of children infected with SARS-CoV2 may …

Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis

…, G Filocamo, R De Marco, F La Torre… - The Journal of …, 2018 - jrheum.org
Objective. Anti-TNF-α agents have significantly changed the management of juvenile idiopathic
arthritis (JIA). We evaluated the safety and efficacy of adalimumab (ADA) and infliximab (…